Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hyperbaric bupivacaine dosage on early complications after spinal anesthesia for orthopedic surgeries
IRCT20160202026328N7Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine in spinal anesthesia complication (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Incidence of early complications after spinal anesthesia and Severity of early complications after spinal anesthesia. Started Dec 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
spinal anesthesia complication
Beyond the preview
Go deeper on IRCT20160202026328N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160202026328N7.